Pheast Therapeutics
Palo Alto
About Pheast Therapeutics
Pheast Therapeutics is a cancer immunotherapy company focused on developing novel checkpoint therapies to harness the innate immune system in the fight against cancer. It was founded in 2020 and headquartered in Palo Alto, California.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $50K – $100K
- Total funding: $76.0M
- Funding stage: Early Stage Venture
- Last round: Series A (Apr 2022)
- Website: pheast.com
Industries & Categories
Biotechnology, Life Science, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/pheast-therapeutics-62723 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.